These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 21476952

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery.
    Atkin T, Comai S, Gobbi G.
    Pharmacol Rev; 2018 Apr; 70(2):197-245. PubMed ID: 29487083
    [Abstract] [Full Text] [Related]

  • 4. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC, Guilleminault C.
    Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
    [Abstract] [Full Text] [Related]

  • 5. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
    Winrow CJ, Renger JJ.
    Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy of insomnia.
    Ioachimescu OC, El-Solh AA.
    Expert Opin Pharmacother; 2012 Jun; 13(9):1243-60. PubMed ID: 22578014
    [Abstract] [Full Text] [Related]

  • 7. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 8. [The newer sedative-hypnotics].
    Sukys-Claudino L, Moraes WA, Tufik S, Poyares D.
    Braz J Psychiatry; 2010 Sep; 32(3):288-93. PubMed ID: 20945020
    [Abstract] [Full Text] [Related]

  • 9. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC, Mungiu OC.
    Rev Med Chir Soc Med Nat Iasi; 2012 Sep; 116(3):862-6. PubMed ID: 23272543
    [Abstract] [Full Text] [Related]

  • 10. Zaleplon: a review of its use in the treatment of insomnia.
    Dooley M, Plosker GL.
    Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
    [Abstract] [Full Text] [Related]

  • 11. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Aug; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 12. Management of insomnia.
    Kirkwood CK.
    J Am Pharm Assoc (Wash); 1999 Aug; 39(5):688-96; quiz 713-4. PubMed ID: 10533351
    [Abstract] [Full Text] [Related]

  • 13. An update of management of insomnia in patients with chronic orofacial pain.
    Almoznino G, Haviv Y, Sharav Y, Benoliel R.
    Oral Dis; 2017 Nov; 23(8):1043-1051. PubMed ID: 28075519
    [Abstract] [Full Text] [Related]

  • 14. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.
    Kumar A, Chanana P, Choudhary S.
    Pharmacol Rep; 2016 Apr; 68(2):231-42. PubMed ID: 26922522
    [Abstract] [Full Text] [Related]

  • 15. Making sleep easier: pharmacological interventions for insomnia.
    Frase L, Nissen C, Riemann D, Spiegelhalder K.
    Expert Opin Pharmacother; 2018 Sep; 19(13):1465-1473. PubMed ID: 30175928
    [Abstract] [Full Text] [Related]

  • 16. Current Phase II investigational therapies for insomnia.
    Zisapel N.
    Expert Opin Investig Drugs; 2015 Mar; 24(3):401-11. PubMed ID: 25423562
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL.
    Ann Intern Med; 2016 Jul 19; 165(2):103-12. PubMed ID: 27136278
    [Abstract] [Full Text] [Related]

  • 18. Benefit-risk assessment of zaleplon in the treatment of insomnia.
    Barbera J, Shapiro C.
    Drug Saf; 2005 Jul 19; 28(4):301-18. PubMed ID: 15783240
    [Abstract] [Full Text] [Related]

  • 19. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ, Goa KL.
    Drugs; 2000 Apr 19; 59(4):865-89. PubMed ID: 10804040
    [Abstract] [Full Text] [Related]

  • 20. Update on emerging drugs for insomnia.
    Sullivan S.
    Expert Opin Emerg Drugs; 2012 Sep 19; 17(3):295-8. PubMed ID: 22920041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.